Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target

被引:355
作者
Barber, Sian C. [1 ]
Mead, Richard J. [1 ]
Shaw, Pamela J. [1 ]
机构
[1] Univ Sheffield, Sch Med, Sect Neurosci, Acad Neurol Unit, Sheffield S10 2RX, S Yorkshire, England
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2006年 / 1762卷 / 11-12期
关键词
amyotrophic lateral sclerosis; oxidative stress; superoxide dismutase; anti-oxidant; clinical trials; therapy;
D O I
10.1016/j.bbadis.2006.03.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cause(s) of amyotrophic lateral sclerosis (ALS) is not fully understood in the vast majority of cases and the mechanisms involved in motor neuron degeneration are multi-factorial and complex. There is substantial evidence to support the hypothesis that oxidative stress is one mechanism by which motor neuron death occurs. This theory becomes more persuasive with the discovery that mutation of the anti-oxidant enzyme, superoxide dismutase I (SOD I), causes disease in a significant minority of cases. However, the precise mechanism(s) by which mutant SOD I leads to motor neuron degeneration have not been defined with certainly, and trials of anti-oxidant therapies have been disappointing. Here, we review the evidence implicating oxidative stress in ALS pathogenesis, discuss how oxidative stress may affect and be affected by other proposed mechanisms of neurodegeneration, and review the trials of various anti-oxidants as potential therapies for ALS. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1051 / 1067
页数:17
相关论文
共 210 条
[1]  
Abe K, 1997, NEUROL RES, V19, P124
[2]   INDUCTION OF NITROTYROSINE-LIKE IMMUNOREACTIVITY IN THE LOWER MOTOR-NEURON OF AMYOTROPHIC-LATERAL-SCLEROSIS [J].
ABE, K ;
PAN, LH ;
WATANABE, M ;
KATO, T ;
ITOYAMA, Y .
NEUROSCIENCE LETTERS, 1995, 199 (02) :152-154
[3]   THE ROLE OF CALCIUM-BINDING PROTEINS IN SELECTIVE MOTONEURON VULNERABILITY IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].
ALEXIANU, ME ;
HO, BK ;
MOHAMED, AH ;
LABELLA, V ;
SMITH, RG ;
APPEL, SH .
ANNALS OF NEUROLOGY, 1994, 36 (06) :846-858
[4]   Immune reactivity in a mouse model of familial ALS correlates with disease progression [J].
Alexianu, ME ;
Kozovska, M ;
Appel, SH .
NEUROLOGY, 2001, 57 (07) :1282-1289
[5]   A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties [J].
Ali, SS ;
Hardt, JI ;
Quick, KL ;
Kim-Han, JS ;
Erlanger, BF ;
Huang, TT ;
Epstein, CJ ;
Dugan, LL .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (08) :1191-1202
[6]   Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways [J].
Allen, S ;
Heath, PR ;
Kirby, J ;
Wharton, SB ;
Cookson, MR ;
Menzies, FM ;
Banks, RE ;
Shaw, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) :6371-6383
[7]   Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients [J].
Almer, G ;
Teismann, P ;
Stevic, Z ;
Halaschek-Wiener, J ;
Deecke, L ;
Kostic, V ;
Przedborski, S .
NEUROLOGY, 2002, 58 (08) :1277-1279
[8]  
Andrus PK, 1998, J NEUROCHEM, V71, P2041
[9]  
Aoyama K, 2000, ANN NEUROL, V47, P524, DOI 10.1002/1531-8249(200004)47:4<524::AID-ANA19>3.0.CO
[10]  
2-5